While ACE inhibitors show promising results against DR and diabetic macular edema, several safety questions related to increased kinin levels can be raised, such as hypotension, angioedema, and pain associated with inflammation, which are B2R-mediated [192,193,194,195]. Here, BDKRB2 is linked to angioedema.